AGREEMENT AND PLAN OF MERGER between CASI PHARMACEUTICALS, INC. and CASI Pharmaceuticals Holdings, Inc. Dated as of January 31, 2023 AGREEMENT AND PLAN OF MERGERMerger Agreement • January 31st, 2023 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 31st, 2023 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of January 31, 2023, is entered into by and between CASI Pharmaceuticals, Inc., a Delaware corporation (“CASI”), and CASI Pharmaceuticals Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands and a wholly-owned subsidiary of CASI (“CASI Cayman” and together with CASI, each a “Party” and collectively the “Parties”).